Disulfone reagents and methods of preparing and using same
AssigneeThe Arizona Disease Control Research Commission
InventorsJacquelyn Gervay-Hague, Michael J. Hadd
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Arizona Disease Control Research Commission
InventorsJacquelyn Gervay-Hague, Michael J. Hadd
Estimating the term…
The present invention provides novel disulfone compounds and methods of preparing and using those compounds to further prepare biologically relevant gem-disulfone analogs of natural enzyme substrates. Methods of using a variety of disulfone compounds as reagents capable of forming symmetrical and non-symmetrical α, β unsaturated gem-disulfones are also provided. There is also provided a disulfone reagent which reacts with both aromatic and aliphatic aldehydes in good to moderate yield to give exclusively the trans isomer. In accordance with further aspects of the present invention, a methodology for stereospecifically preparing potential gem-disulfone enzyme inhibitors is provided. A synthetic design which allows easy substitution of functional groups so that a number of substrate analogs can be synthesized readily is also provided. In addition, there is provided a new class of compounds which are potential glycosyl transferase inhibitors having characteristics which can inhibit the incorporation of sialic acid and/or fucose into glycoconjugates present at the surface of certain cancer cells. Additionally, a class of potent disulfone-linked catechol-based enzyme inhibitors, such as HIV-1 integrase inhibitors, is provided.
A method of using a disulfone reagent for preparing biologically relevant disulfones, said method comprising the steps of:
A compound having the formulation of:
A pharmaceutical formulation comprising a compound having the following formulation:
A compound having the formulation of:
A pharmaceutically acceptable derivative of a compound having the following formulation:
Dependencies are inferred from the claim text.